India to Philippines: Apixaban Export Trade Route
India has recorded 94 verified shipments of Apixaban exported to Philippines, representing a combined trade value of $2.1M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $22.3K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 40% of total export value with 22 shipments worth $843.1K USD. On the buying side, TO THE ORDER is the largest importer in Philippines with $601.4K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Apixaban corridor is one of India's established pharmaceutical export routes, with 94 shipments documented worth a combined $2.1M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 40% of all export value, reflecting the consolidated nature of India's apixaban manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $22.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with apixaban's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #13 among India's top apixaban export destinations globally.
On the import side, key buyers of Indian apixaban in Philippines include TO THE ORDER, VIATRIS PHARMACEUTICALS INC,, ONE DEXCEL PHARMA INC. and 16 others. TO THE ORDER is the single largest importer with 16 shipments valued at $601.4K USD.
